Back to Search
BRUCE GOLDSTEIN, M.D.
M.D.
Dermatology Physician
NPI: 1124008693Individual
Specialties, Licenses & Credentials
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
41324(MA)
Research & Publications (20)
Irritability without elation in a large bipolar youth sample: frequency and clinical description.
PMID 19465878·J Am Acad Child Adolesc Psychiatry·2009
8-other
Inflammatory signaling: another drug target to improve glycemic control in type 2 diabetes.
PMID 19468293·Clin Transl Sci·2008
8-other
Bactericidal activity and resistance development profiling of dalbavancin.
PMID 17220411·Antimicrob Agents Chemother·2007
8-other
Clinical translation of "a diabetes outcome progression trial": ADOPT appropriate combination oral therapies in type 2 diabetes.
PMID 17409340·J Clin Endocrinol Metab·2007
8-other
Effect of tesaglitazar, a dual PPAR alpha/gamma agonist, on glucose and lipid abnormalities in patients with type 2 diabetes: a 12-week dose-ranging trial.
PMID 17166340·Curr Med Res Opin·2006
4-observational
Closing the gap between clinical research and clinical practice: can outcome studies with thiazolidinediones improve our understanding of type 2 diabetes?
PMID 16846404·Int J Clin Pract·2006
6-review
Reductions in biomarkers of cardiovascular risk in type 2 diabetes with rosiglitazone added to metformin compared with dose escalation of metformin: an EMPIRE trial sub-study.
PMID 16968575·Curr Med Res Opin·2006
3-trial
Microbiologic characterization of isolates from a dalbavancin clinical trial for catheter-related bloodstream infections.
PMID 16458124·Diagn Microbiol Infect Dis·2006
8-other
Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets.
PMID 15677487·Diabetes·2005
6-review
Intensive insulin therapy regimens: is there a difference in patient satisfaction?
PMID 16929375·Nat Clin Pract Endocrinol Metab·2005
8-other
Adiponectin: A novel adipokine linking adipocytes and vascular function.
PMID 15181024·J Clin Endocrinol Metab·2004
6-review
Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea.
PMID 12852706·Clin Ther·2003
3-trial
Are the metabolic effects of rosiglitazone influenced by baseline glycaemic control?
PMID 12803733·Curr Med Res Opin·2003
3-trial
Insulin resistance: from benign to type 2 diabetes mellitus.
PMID 14668698·Rev Cardiovasc Med·2003
6-review
Protein-tyrosine phosphatases: emerging targets for therapeutic intervention in type 2 diabetes and related states of insulin resistance.
PMID 12050202·J Clin Endocrinol Metab·2002
6-review
Insulin resistance as the core defect in type 2 diabetes mellitus.
PMID 12231073·Am J Cardiol·2002
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8 ATWOOD DR, SUITE 304
NORTHAMPTON, MA 01060 - Phone
- (413) 586-5798
Quick Facts
- NPI
- 1124008693
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile